share_log

MusclePharm (OTCMKTS:MSLP) Stock Crosses Below 200 Day Moving Average of $0.21

MusclePharm (OTCMKTS:MSLP) Stock Crosses Below 200 Day Moving Average of $0.21

MusclePharm(場外交易代碼:MSLP)股價跌破200日移動均線0.21美元
Defense World ·  2022/10/06 03:11

MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.21 and traded as low as $0.13. MusclePharm shares last traded at $0.16, with a volume of 5,541 shares trading hands.

在週三的交易中,MusclePharmCo.的股價跌破了200日移動均線,200日移動均線切入位0.21美元,最低交易價格為0.13美元,最後報0.16美元,總成交量為5541股。

MusclePharm Trading Up 11.7 %

MusclePharm股價上漲11.7%

The stock has a 50-day moving average of $0.18 and a two-hundred day moving average of $0.21. The firm has a market cap of $5.26 million, a price-to-earnings ratio of -0.27 and a beta of 0.38.

該股的50日移動均線切入位在0.18美元,200日移動均線切入位在0.21美元。該公司市值為526萬美元,市盈率為-0.27倍,貝塔係數為0.38。

MusclePharm Company Profile

MusclePharm公司簡介

(Get Rating)

(獲取評級)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.

公司在美國和國際上開發、製造、營銷和分銷運動營養品和營養補充劑。該公司提供一系列高性能粉末、膠囊、片劑、凝膠和隨時可用的零食。該公司的MusclePharm品牌產品組合包括戰鬥蛋白粉和戰鬥擠壓蛋白棒;以及支鏈氨基酸、肌酸、谷氨醯胺、肉鹼、共軛亞油酸、魚油、多種維生素和其他產品等基本補充劑。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
  • 3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
  • Don't Forget About These Cheap, Fundamentally Strong Tech Stocks
  • Bellwether RPM International Pops On Results
  • Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
  • Hot Potato: Lamb Weston Stock Confirms a Top
  • 免費獲取StockNews.com關於MusclePharm的研究報告(MSLP)
  • 隨着治療競賽升温,3只阿爾茨海默病股票將被買入
  • 不要忘記這些廉價的、從根本上強勁的科技股
  • 領頭羊RPM國際流行業績
  • Rivian打掉了包袱,但仍有很多事情要做
  • 辣土豆:韋斯頓羊肉庫存漲幅居前

Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.

接受MusclePharm日報的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊收到對MusclePharm和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論